CN105267506A - Medicine for treating pelvic inflammatory disease - Google Patents
Medicine for treating pelvic inflammatory disease Download PDFInfo
- Publication number
- CN105267506A CN105267506A CN201510881468.0A CN201510881468A CN105267506A CN 105267506 A CN105267506 A CN 105267506A CN 201510881468 A CN201510881468 A CN 201510881468A CN 105267506 A CN105267506 A CN 105267506A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- grams
- inflammatory disease
- pelvic inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a medicine for treating a pelvic inflammatory disease. The medicine is prepared from, by weight, 10 parts of lotus leaves, 5 parts of pagoda tree fruits, 5 parts of aloe, 12 parts of barbed skullcap herbs, 3 parts of American ginseng, 5 parts of mulberry leaves, 10 parts of broom cypress fruits, 12 parts of semen euryales, 9 parts of semen cassiae, 5 parts of rhizoma drynariae, 3 parts of rhizoma acori graminei and 2 parts of Chinese sage herbs. The clinical trial shows that the pelvic inflammatory disease can be safely and effectively treated through the medicine.
Description
Technical field
The present invention relates to a kind of Chinese medicine, especially relate to a kind of medicine for the treatment of pelvic inflammatory disease.
Background technology
Pelvic inflammatory disease refers to that female internal genital organs and connective tissue basin peritoneum around thereof are inflamed.Primary disease is mainly in Status of Married Child-bearing aged Women, in recent years due to the various factors such as to increase of the change of consciousness and family planning operation, makes pelvic inflammatory disease sickness rate in rising trend, has become common gynecological disease, frequently-occurring disease.Due to long period inflammatory stimulus, local patholoic change is fibrous connective tissue hypertrophy, whenever menstrual period or other reason cause pelvic congestion, thus there is stomachache, dysmenorrhea, menoxenia, the very then symptom such as infertility, general anti-inflammatory treatment curative effect is not good enough, and the state of an illness is often delayed difficult.Motherland's traditional medicine treats this disease certain advantage, and the long-term practice through inventor draws, Chinese medicine is controlled pelvic inflammatory disease and had better effect, and obtains good effect.
At present the effective medicine of generally recognized as safe is still lacked at present for pelvic inflammatory disease.
Involved by Chinese medicine of the present invention, the present Research of medical material is as follows:
Folium Nelumbinis
[source] this product is the dried leaves of nymphaeaceae plant lotus NelumbonuciferaGaertn..
[function cures mainly] clearing away summer-heat; Sending up the lucid YANG; Dissipating blood stasis stops blooding.
The Fructus Sophorae
[source] this product is the dry mature fruit of leguminous plant Chinese scholartree SophorajaponicaL..
[function cures mainly] clearing away heat-fire, cooling blood for hemostasis.
Aloe
Juice in the leaf that [source] is liliaceous plant Aloe vulgaris, Aloe ferox Miller or stripe aloe vera is through concentrated dry product.
[function cures mainly] heat clearing away, relieving constipation, parasite killing.
Herba Scutellariae Barbatae
[source] this product is the dry herb of labiate Herba Scutellariae Barbatae ScutellariabarbataDon [S.rivularisWall].
[function cures mainly] heat-clearing and toxic substances removing, blood stasis dispelling diuresis.
Radix Panacis Quinquefolii
[source] this product is the dry root of Araliaceae Radix Panacis Quinquefolii PanaxquinquefoliumL..
[function cures mainly] boosting qi and nourishing yin, clearing away heat and promoting production of body fluid.
Folium Mori
[source] this product is the dried leaves of moraceae plants Mulberry MorusalbaL..
[function cures mainly] expelling wind and clearing away heat, cooling blood for improving eyesight.
The Fructus Kochiae
[source] this product is chenopod Fructus Kochiae Kochiascoparia(L.) dry mature fruit of Schrad..
[function cures mainly] clearing away heat-damp and promoting diuresis, dispelling wind for relieving itching.
Semen Euryales
[source] this product is the dry mature kernal of nymphaeaceae plant Gorgon euryale EuryaleferoxSalisb..
[function cures mainly] supplementing the kidney to control the nocturnal, spleen reinforcing antidiarrheal, damp eliminating leukorrhagia stopping.
Semen Cassiae
[source] is the mature seed of leguminous plant Semen Cassiae.
[function cures mainly] expelling wind and clearing away heat, detoxification and promoting urination.
Rhizoma Drynariae
[source] this product is Plants of Polypodiaceae Mongolian oak Herba pteridii latiusculi Drynariafortunei(Kunze) dry rhizome of J.Sm..
[function cures mainly] the kidney invigorating, invigorates blood circulation, hemostasis.
Rhizoma Acori Graminei
[source] this product is the dry rhizome of acorus gramineus araceae plant AcorustatarinowiiSchott.
[function cures mainly] has one's ideas straightened out, and eliminating phlegm is regulated the flow of vital energy, and invigorates blood circulation, and loose wind, dries.
Herba Salviae Chinensis
[source] is Lamiaceae Salvia platymiscium Herba Salviae Chinensis SalviachinensiaBenth., with all herbal medicine.
[function cures mainly] heat-clearing and toxic substances removing, invigorating blood circulation analgesia.
Summary of the invention
The present invention aims to provide a kind of medicine for the treatment of pelvic inflammatory disease, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing pelvic inflammatory disease.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of medicine for the treatment of pelvic inflammatory disease, it is characterized in that, be prepared from by the medical material of following weight proportion: 10 parts, Folium Nelumbinis, the Fructus Sophorae 5 parts, Aloe 5 parts, Herba Scutellariae Barbatae 12 parts, Radix Panacis Quinquefolii 3 parts, 5 parts, Folium Mori, the Fructus Kochiae 10 parts, Semen Euryales 12 parts, Semen Cassiae 9 parts, Rhizoma Drynariae 5 parts, Rhizoma Acori Graminei 3 parts, Herba Salviae Chinensis 2 parts.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects the outpatient service female patient of 75 routine pelvic inflammatory disease altogether between in June ,-2015 in February, 2014, age 21-60 year, the course of disease 1 month-36 months.Be divided at random: treatment group 63 example, blank group 12 example.The two groups of data such as age, state of an illness there was no significant differences, have comparability.
2, diagnostic criteria
" Chinese medical disease Standardization of diagnosis and curative effect " that diagnosis basis State Administration of Traditional Chinese Medicine issues:
(1) lower abdomen and lumbago, lower abdomen falling inflation, lumbosacral region are ached, after fatigue of being everlasting, sexual intercourse, defecation time, increase the weight of before and after menstruation, can increase or leucorrhoea grow in quantity with low grade fever, menstruation;
(2) gynecologial examination: abdominal part has slight tenderness, can touch streak thing in side, uterus or bilateral during fallopian tube inflammation, and have tenderness, and during the inflammation of pelvic cavity connective tissue, side, uterus or bilateral have lamellar to thicken and tenderness;
(3) all cases all makes a definite diagnosis prompting through ultrasonic, and uterus heavy wall and pelvic cavity have hydrops, or has fallopian tube increase thick or have cystic enclosed mass etc.
3, test method
The oral the present invention of 3.1 treatment group according to the obtained capsule of specific embodiment 1, sooner or later each once, 10 days courses for the treatment of, the person of being in a bad way follows the doctor's advice the meal with wine amount of adding.
3.2 blank group oral placebo capsules, sooner or later respectively once, 10 days courses for the treatment of.
4, criterion of therapeutical effect and therapeutic outcome
4.1 criterion of therapeutical effect
Recovery from illness: Clinical symptom and sign all disappears, B ultrasonic shows that list or bilateral adnexa recover normal, and inflammatory masses of pelvic cavity and inflammatory exudate all disappear;
Take a turn for the better: Clinical symptom and sign is clearly better, B ultrasonic shows that list or bilateral adnexa increase and slightly takes a favorable turn, inflammatory masses of pelvic cavity and inflammatory exudate reduce or reduce >=and 1/3;
Invalid: clinical symptoms, sign, ultrasound diagnosis is all without improvement.
4.2 treatment statistical results are in table 1.
Table 1 liang group comparitive study
Group | n | Recovery from illness | Take a turn for the better | Invalid | Total effective rate (%) | Untoward reaction example |
Treatment group | 63 | 17(26.9%) | 38(60.3%) | 8(12.7%) | 87.3% | 0 |
Blank group | 12 | 0(0.0%) | 2(16.6%) | 10(83.4%) | 16.6% | 0 |
For proving that the present invention has good curative effect, enumerate model case as follows:
1, Xue ×, female, 32 years old, patient has a dull ache when telling its lower abdomen sense, coldness of the body and aversion to cold, delayed menstrual cycle amount is few or irregular, the dark fixture block of color, leukorrhagia is on the high side, color white matter is rare, gas raw meat, tongue is dark, tongue is white, deep pulse is string slightly, local hospital is gone to go to a doctor subsequently in time, hospital is waited on a small quantity by normal ultrasonic examination prompting pelvic hydrops and is diagnosed as pelvic inflammatory disease, rear hospital adopts conventional western medicine treatment, treat effect after a week and there is no material alterations, after give treatment by Chinese herbs of the present invention, after taking a course for the treatment of, above-mentioned symptom obviously takes a turn for the better to some extent, continuous with recovering normal after two courses for the treatment of, check display no abnormality seen subsequently.
2, Song ×, female, 37 years old, operating pressure was comparatively large recently, can feel stomachache after work, especially based on both sides lower abdomen, and with insomnia, lassitude, all over the body discomfort.Lumbosacral region is miserable, leucorrhea yellow skin amount is many, stench is unpleasant, phenomenon such as companion frequent micturition, urgent micturition etc., red tongue, yellow and greasy fur, stringy and rolling pulse, go to local hospital to be pointed out by ultrasonic examination subsequently: endometrial thickness owes clear, pelvic hydrops is a small amount of, is diagnosed as chronic pelvic inflammatory disease, hospital adopts treatment with western, and symptom is not substantive to some extent to be alleviated.After give treatment by Chinese herbs of the present invention, after taking a course for the treatment of, stomachache phenomenon takes a turn for the better to some extent, and after continuing to take two courses for the treatment of, state of an illness rehabilitation is complete, and so far without recurring.
Visible, the present invention adopts the formula of science and suitable proportioning, with clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling for principle for the treatment of, adopts between each medicine and cooperatively interacts, synergism, and made Chinese medicine can safe and effective treatment pelvic inflammatory disease.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Specific embodiment 1
Take: 10 grams, Folium Nelumbinis, the Fructus Sophorae 5 grams, Aloe 5 grams, Herba Scutellariae Barbatae 12 grams, Radix Panacis Quinquefolii 3 grams, 5 grams, Folium Mori, the Fructus Kochiae 10 grams, Semen Euryales 12 grams, Semen Cassiae 9 grams, Rhizoma Drynariae 5 grams, Rhizoma Acori Graminei 3 grams, Herba Salviae Chinensis 2 grams, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, incapsulate shell, the capsule of normal 1 day consumption must be met.
Be used for the treatment of pelvic inflammatory disease.Oral, every bu is taken for twice sooner or later.
Specific embodiment 2
Take: 10 grams, Folium Nelumbinis, the Fructus Sophorae 5 grams, Aloe 5 grams, Herba Scutellariae Barbatae 12 grams, Radix Panacis Quinquefolii 3 grams, 5 grams, Folium Mori, the Fructus Kochiae 10 grams, Semen Euryales 12 grams, Semen Cassiae 9 grams, Rhizoma Drynariae 5 grams, Rhizoma Acori Graminei 3 grams, Herba Salviae Chinensis 2 grams, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, pulverize, the powder of normal 1 day consumption must be met.
Be used for the treatment of pelvic inflammatory disease.Oral, every bu is taken for twice sooner or later.
Specific embodiment 3
Take: 10 grams, Folium Nelumbinis, the Fructus Sophorae 5 grams, Aloe 5 grams, Herba Scutellariae Barbatae 12 grams, Radix Panacis Quinquefolii 3 grams, 5 grams, Folium Mori, the Fructus Kochiae 10 grams, Semen Euryales 12 grams, Semen Cassiae 9 grams, Rhizoma Drynariae 5 grams, Rhizoma Acori Graminei 3 grams, Herba Salviae Chinensis 2 grams, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, then add appropriate dextrin and correctives, granulate according to this area common process, packaging, can obtain the granule meeting normal 1 day consumption.
Be used for the treatment of pelvic inflammatory disease.Oral, every bu is taken for twice sooner or later.
Claims (1)
1. treat the medicine of pelvic inflammatory disease for one kind, it is characterized in that, be prepared from by the medical material of following weight proportion: 10 parts, Folium Nelumbinis, the Fructus Sophorae 5 parts, Aloe 5 parts, Herba Scutellariae Barbatae 12 parts, Radix Panacis Quinquefolii 3 parts, 5 parts, Folium Mori, the Fructus Kochiae 10 parts, Semen Euryales 12 parts, Semen Cassiae 9 parts, Rhizoma Drynariae 5 parts, Rhizoma Acori Graminei 3 parts, Herba Salviae Chinensis 2 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510881468.0A CN105267506A (en) | 2015-12-07 | 2015-12-07 | Medicine for treating pelvic inflammatory disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510881468.0A CN105267506A (en) | 2015-12-07 | 2015-12-07 | Medicine for treating pelvic inflammatory disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105267506A true CN105267506A (en) | 2016-01-27 |
Family
ID=55137896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510881468.0A Pending CN105267506A (en) | 2015-12-07 | 2015-12-07 | Medicine for treating pelvic inflammatory disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105267506A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550709A (en) * | 2013-11-12 | 2014-02-05 | 夏增香 | Traditional Chinese medicine for treating chronic pelvic inflammation |
CN103961438A (en) * | 2014-06-03 | 2014-08-06 | 刘洪华 | Traditional Chinese medicine for treating qi stagnation and blood stasis type pelvic inflammation |
-
2015
- 2015-12-07 CN CN201510881468.0A patent/CN105267506A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550709A (en) * | 2013-11-12 | 2014-02-05 | 夏增香 | Traditional Chinese medicine for treating chronic pelvic inflammation |
CN103961438A (en) * | 2014-06-03 | 2014-08-06 | 刘洪华 | Traditional Chinese medicine for treating qi stagnation and blood stasis type pelvic inflammation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101700358B (en) | Medicine for treating acute and chronic nonspecific ulcerative colitis and preparation method thereof | |
CN102228603B (en) | Chinese medicine for treating retention of urine | |
CN103007124B (en) | Chinese medicine preparation for treating gynecologic inflammation | |
CN105477564A (en) | Traditional Chinese medicine composition for treating prosopalgia | |
CN101569699B (en) | Pharmaceutical composition for treating prostatitis and preparation method thereof | |
CN103520669B (en) | The Chinese medicine for the treatment of phlegm-damp accumulation symptom pattern of syndrome obstruction of qi in the chest and cardialgia | |
CN102293968B (en) | Traditional Chinese medicine for preventing and treating hiccup disease | |
CN103381266A (en) | Traditional Chinese medicine for treating nervous vomiting | |
CN102133370B (en) | Traditional Chinese medicine pelvic inflammatory disease clearing decoction for curing chronic pelvic inflammatory diseases | |
CN104606592A (en) | Pharmaceutical preparation treating pelvic inflammation by using rhizoma smilacis glabrae and dandelions as main raw materials | |
CN104107280A (en) | Pharmaceutical composition for treating chronic pelvic inflammation, and preparation method and application thereof | |
CN103520697A (en) | Traditional Chinese medicine for treating qi-yin deficiency syndrome type chest stuffiness and pains | |
CN103611027B (en) | The pharmaceutical composition of a kind of clinical prevention, nursing and treatment trichomonal vaginitis | |
CN105106494A (en) | Traditional Chinese medicine for treating uterine fibroid | |
CN102935214B (en) | Traditional Chinese medicinal composition for treating uremia | |
CN105267506A (en) | Medicine for treating pelvic inflammatory disease | |
CN101912511B (en) | Chinese medicinal preparation for treating qi-blood deficiency polycystic ovary syndrome | |
CN1686204A (en) | Medicine for treating different diseases caused by fire accumulations and six gatherings | |
CN102641441B (en) | Traditional Chinese medicine for treating phlegmatic disease | |
CN102671032B (en) | Traditional Chinese medicine for treating recurrent aphthae | |
CN101983645A (en) | Medicament for treating acute appendicitis | |
CN101129571A (en) | Oral liquid of prunella spike | |
CN104606593A (en) | Preparation process of dandelion-rhizoma smilacis glabrae pelvic inflammation-curing capsule preparation | |
CN105311477A (en) | Traditional Chinese medicine for treating chronic pelvic inflammatory disease | |
CN104873866A (en) | Dandelion and rhizoma smilacis glabrae medical preparation for treating pelvic inflammation and detection method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160127 |